Updates are available Correction dated 2024-03-12
Click to view Correction: https://doi.org/10.1038/s41531-024-00674-6
-
Authors
Holmes, Sophie E.
Honhar, Praveen http://orcid.org/0000-0001-9073-6270
Tinaz, Sule http://orcid.org/0000-0003-2220-8278
Naganawa, Mika http://orcid.org/0000-0002-4408-2621
Hilmer, Ansel T. http://orcid.org/0000-0002-8105-1381
Gallezot, Jean-Dominique
Dias, Mark
Yang, Yanghong
Toyonaga, Takuya
Esterlis, Irina
Mecca, Adam
Van Dyck, Christopher
Henry, Shannan
Ropchan, Jim
Nabulsi, Nabeel http://orcid.org/0000-0001-8129-0051
Louis, Elan D.
Comley, Robert http://orcid.org/0000-0001-7546-5492
Finnema, Sjoerd J.
Carson, Richard E.
Matuskey, David http://orcid.org/0000-0001-7508-6572
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS124819, R21NS120116)
AbbVie
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
- License Information
-
More Information
Article History
Received: 3 August 2023
Accepted: 6 February 2024
First Online: 24 February 2024
Change Date: 12 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41531-024-00674-6
Competing interests
: R.C. and S.J.F. are full-time employees of AbbVie but their employment does not constitute any competing interest for the content presented in this article. All other authors declare no competing interests.
